2020
DOI: 10.1016/j.clnesp.2020.03.017
|View full text |Cite
|
Sign up to set email alerts
|

Serum uric acid concentration is not associated with handgrip strength, lean body mass or survival in gastrointestinal cancer patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 31 publications
0
5
0
Order By: Relevance
“…In vivo, it may offer a neuroprotective advantage in the neurodegenerative Alzheimer's disease [18], schizophrenia [19], Parkinson's disease [20], multiple sclerosis [21], and serves as a depression biomarker [22]. SUA concentrations are linked to muscle strength and lean mass [23], although this was not shown in gastrointestinal tract cancer patients [24]. SUA may serve as a risk factor to predict poor thyroid function [25] or an indicator of malnutrition [15].…”
Section: Uric Acid and Goutmentioning
confidence: 99%
See 1 more Smart Citation
“…In vivo, it may offer a neuroprotective advantage in the neurodegenerative Alzheimer's disease [18], schizophrenia [19], Parkinson's disease [20], multiple sclerosis [21], and serves as a depression biomarker [22]. SUA concentrations are linked to muscle strength and lean mass [23], although this was not shown in gastrointestinal tract cancer patients [24]. SUA may serve as a risk factor to predict poor thyroid function [25] or an indicator of malnutrition [15].…”
Section: Uric Acid and Goutmentioning
confidence: 99%
“…Allopurinol, a ULT medicine, has not shown any efficacy in the prevention of a first gout flare in patients with asymptomatic hyperuricemia [84]. Fundamentally, SUA level is associated with physical capacity and muscle strength in healthy subjects [23,24] and may only be a biological marker of non-gout conditions such as cardiovascular damage but is not a risk factor for its development [51]. Controversially, pseudogout, which is caused by calcium pyrophosphate deposition (CPPD), could have the same inflammatory symptoms as gout without hyperuricemia [85].…”
Section: The Causes Of Hyperuricemia Irrelevant To Goutmentioning
confidence: 99%
“…In vivo, it may offer a neuroprotective advantage in the neurodegenerative Alzheimer's disease [18], schizophrenia [19], Parkinson's disease [20], multiple sclerosis [21], and serves as a depression biomarker [22]. SUA concentrations are linked to muscle strength and lean mass [23], although this was not shown in gastrointestinal tract cancer patients [24]. SUA may serve as a risk factor to predict poor thyroid function [25] or an indicator of malnutrition [15].…”
Section: Uric Acid and Goutmentioning
confidence: 99%
“…Allopurinol, a ULT medicine, has not shown any efficacy in the prevention of a first gout attack in patients with asymptomatic hyperuricemia [84]. Fundamentally, SUA level is associated with physical capacity and muscle strength in healthy subjects [23,24] and may only be a biological marker of non-gout conditions such as cardiovascular damage but is not a risk factor for its development [51]. Controversially, the pseudo-gout, which is caused by calcium pyrophosphate deposition (CPPD) deposition, could have the same inflammatory symptoms as gout without hyperuricemia [85].…”
Section: The Causes Of Hyperuricemia Irrelevant To Goutmentioning
confidence: 99%
“…In addition, serum uric acid is another important indicator to evaluate the prognosis of cancer. Related studies have confirmed that elevated serum uric acid levels are associated with the incidence and mortality risk of various diseases such as gastric cancer, colon cancer, renal cell carcinoma, and liver cancer [ 5 ]. Clinical studies have confirmed that hyperuricemia not only causes gout but also is closely related to kidney disease, cardiovascular disease, and endocrine and metabolic diseases.…”
Section: Introductionmentioning
confidence: 99%